Bhaskar Anand

VP, Chief Accounting Officer, REATA PHARMACEUTICALS INC.

Companies

Summit TherapeuticsChief Accounting Officer Apr 4, 2024 to now¹
REATA PHARMACEUTICALS INCVP, Chief Accounting Officer Nov 15, 2021 to Sep 26, 2023²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Oct 21, 2025Granted 26,680 shares at $18.74 of Summit Therapeutics³
Sep 11, 2024Granted 22,026 shares at $22.70 of Summit Therapeutics⁵
Sep 26, 2023Returned to company 24,089 shares of REATA PHARMACEUTICALS INC⁴
Sep 5, 2023Sold 406 shares at $169.20 of REATA PHARMACEUTICALS INC⁶
Aug 16, 2023Sold 210 shares at $168.42 of REATA PHARMACEUTICALS INC⁷
Aug 15, 2023Sold 193 shares at $169.06 of REATA PHARMACEUTICALS INC⁷
Jun 14, 2023Sold 2,343 shares at $102.11 of REATA PHARMACEUTICALS INC⁸
Jun 14, 2023Exercised options 1,562 shares at $27.32 of REATA PHARMACEUTICALS INC⁸
May 16, 2023Sold 136 shares at $81.10 of REATA PHARMACEUTICALS INC⁹
May 15, 2023Sold 950 shares at $85.98 of REATA PHARMACEUTICALS INC⁹
Mar 7, 2023Sold 165 shares at $84.58 of REATA PHARMACEUTICALS INC¹⁰
Mar 3, 2023Sold 820 shares at $87.47 of REATA PHARMACEUTICALS INC¹¹
Mar 1, 2023Granted 3,000 shares of REATA PHARMACEUTICALS INC¹²
Jan 3, 2023Granted 8,250 shares of REATA PHARMACEUTICALS INC¹³
Jan 3, 2022Granted 12,500 shares of REATA PHARMACEUTICALS INC¹⁴

The numbers on this page point here. Each one links to the record it came from.